Objective To estimate the association between pregnancy glucose values in women without recognized pregestational diabetes or gestational diabetes and cardiometabolic risk in their children.
Conclusion
In Mexican American women without recognized pregestational diabetes or gestational diabetes, we found an association between increasing pregnancy glucose values and the children's diastolic and systolic BPs and WC at 7 years of age. Whether interventions to reduce pregnancy glucose values, even if below levels diagnostic of overt disease, will mitigate high BP and abdominal obesity in late childhood remains to be determined.
(J Pediatr 2012;-:---).
S imilar to other ethnic groups in the United States, cardiovascular disease is the leading cause of death among Mexican Americans. 1 Compared with non-Hispanic whites, Mexican American adults are at greater risk of cardiovascular disease mortality, 2 as well as several cardiovascular disease risk factors, including metabolic syndrome 2 and diabetes, 1 which are likely related to the high prevalence of obesity in this population. 1 Mexican American children are more likely to be overweight or obese than are non-Hispanic white children. 4 Among Mexican American children, 30% of 2-to 5-year-olds and 43% of 6-to 11-year-olds are overweight or obese, with the corresponding prevalence in non-Hispanic whites at 23% and 32%, respectively. 3 A widely accepted hypothesis is that exposure to abnormal maternal fuel metabolism in utero, resulting from maternal diabetes at one end of the spectrum and maternal undernutrition at the other, programs a fetus for later life morbidity, including obesity, diabetes, hypertension, and heart disease. 5, 6 In women without recognized pregestational diabetes or gestational diabetes mellitus (GDM), an increasing trend in offspring weight-for-age across increasing quartiles of pregnancy glucose has also been reported, 7 yet there is a paucity of data on the association between in utero exposure to levels of maternal glycemia below those diagnostic of disease and childhood cardiometabolic risk. In women free of GDM, there appears to be a continuous association between increasing maternal glucose levels and the risk of several perinatal complications 8, 9 ; thus it is plausible that increasing pregnancy glucose levels below those diagnostic of disease could also be associated with longer-term adverse outcomes in the offspring.
The current study examines the association between increasing pregnancy glucose levels in women without recognized pregestational diabetes or GDM and cardiometabolic risk factors in their children at 7 years of age. 
Methods
The mothers and children were participants in the Center for the Health Assessment of Mothers and Children of Salinas study, a longitudinal birth cohort of low-income Mexican Americans. Pregnant women were eligible if they sought prenatal care at 6 health clinics between October 1999 and October 2000, were <20 weeks' gestation, were 18 years or older, were eligible for state-sponsored health care (Medi-Cal), and intended to deliver at Natividad Medical Center (a county hospital in Monterey County, California). A total of 601 women were enrolled and 485 were followed until the delivery of a full-term ($37 weeks' gestation), liveborn singleton. Study participants provided written informed consent and all research activities were approved by the University of California-Berkeley Committee for the Protection of Human Subjects. Measurements of pregestational and gestational plasma glucose, as well as diabetes and GDM diagnoses, were abstracted from the medical record by a registered nurse. This analysis includes women without type 1 diabetes, type 2 diabetes, or GDM that had a plasma glucose value measured 1 hour after a 50-g oral glucose challenge test (screening GCT) performed within the recommended window of 24 to 28 weeks' gestation. 10 Of the 485 women delivering fullterm, liveborn singletons, we excluded 11 with recognized pregestational diabetes, 1 with possible unrecognized pregestational diabetes (glucose level >200 mg/dL [11.1 mmol/L] on >1 occasion during pregnancy), and 5 cases of GDM, identified by the results of a diagnostic 100-g, 3-hour oral glucose tolerance test (OGTT) following an abnormal GCT. During this period in this setting, the diagnosis of GDM was based on the National Diabetes Data Group criteria but no follow-up diagnostic OGTT; 23 women with diagnoses of GDM in their medical record who did not meet the diagnostic criteria because they likely received treatment for pregnancy hyperglycemia; and 113 woman whose screening tests were not performed within the recommended window of 24-28 weeks' gestation. 10 None of the remaining 331 women met the lower plasma glucose thresholds for GDM of the American Diabetes Association. 11 Of these 331 women, 211 had children with nonfasting total cholesterol and triglyceride levels, blood pressure (BP), or waist circumference (WC) measurements at 7 years of age.
Nonfasting blood samples were collected from the children between March 2007 and November 2008. Blood samples were immediately processed, with sera stored at À80 C until shipment on dry ice to the US Centers for Disease Control and Prevention (Atlanta, Georgia), where they were analyzed. Measurement of triglycerides (mg/dL) and cholesterol (mg/dL) in serum were made using standard enzymatic methods (Roche Chemicals, Indianapolis, Indiana).
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BP measurements (mm Hg) were made after the child had been sitting quietly for a minimum of 2 minutes; children were sitting with their arm relaxed either in their lap or on a low table. BP was measured up to 4 times on the same arm using a Dinamap 9300 (Critikon Corp, Tampa, FL), an automatic BP machine that allows inflation pressure to be set at an appropriate level for children. One child had only 1 BP measurement. Trials were averaged for children with 2 BP measurements (n = 3); we averaged the last 2 trials for those with 3 BP measurements (n = 174). If any readings were unusually high (for boys: systolic BP [SBP] >115 mm Hg or diastolic BP [DBP] >76 mm Hg, for girls: SBP >113 mm Hg or DBP >75 mm Hg), the cuff was removed and the child rested for at least 5 minutes prior to a fourth measurement. For children with 4 measurements available (n = 11), we excluded the first measurement and averaged the 2 trials in which mean arterial pressure values were closest to each other.
WC (cm) was measured with a tape against the skin at above the crest of the ileum while the children were standing upright. Measurements were recorded to the nearest 0.1 cm after the child exhaled. WC was measured in triplicate, with the tape loosened prior to repeating each measurement; we took the mean of the 3 WC trials.
From questionnaires administered to the mother during pregnancy, we obtained data on: smoking status (yes or no), poverty (living above versus at or below the federal poverty line, which represents an annual income of $17 650 for a family of 4 13 ), and sugar-sweetened beverage consumption. Sugar-sweetened beverage consumption prior to the screening test was used as a proxy for dietary added sugars and ascertained from the women at the end of the second trimester (mean gestational age = 26.7 weeks, SD = 2.0); women were asked how often in the past 3 months they drank nondiet soda, fruit juice, and fruit drinks, the frequency of consumption was coded in times per week. Prepregnancy weight was obtained from several sources, according to the following hierarchy: (1) as recorded in the medical record (n = 189); (2) self-reported on the pregnancy questionnaire (n = 16); (3) from an early prenatal weight measurement (<13 weeks' gestational age; n = 2); or (4) calculated by a regression line that used all prenatal weight measurements and corresponding gestational ages (n = 4). In the subset of women with prepregnancy weight data available in the medical record, from the pregnancy questionnaire, and from an early prenatal weight measurement (n = 108), prepregnancy weight from the medical record was significantly and positively correlated with the early prenatal weight (Spearman's rho = 0.96, P < .0001); self-reported prepregnancy weight was also significantly and positively correlated with the early prenatal weight (Spearman's rho = 0.96, P < .001). From the medical record, we abstracted gestational weight gained just prior to the THE JOURNAL OF PEDIATRICS www.jpeds.com Vol. -, No. -glucose test (kg) and gestational age at this pregnancy weight measurement (weeks), as well as infant birth weight (grams) and gestational age at birth (weeks); maternal height was measured by study staff. Only gestational weight gain occurring prior to the exposure could confound the association of interest 14 ; thus, prepregnancy weight was subtracted from the nearest prenatal weight measurement taken prior to the glucose test to calculate the amount of weight gained up until the time of the glucose test.
Because there is no standard definition for abnormal cardiometabolic risk factors in children, we classified each cardiometabolic risk factor as increased if it was at or above the upper quartile for that outcome. The 75th percentile was determined from sex-and age-specific, nationally representative WC data for Mexican American youth 15 and the study cohort sex-specific distributions; for all other cardiometabolic risk factors, the study cohort distribution was used to determine the 75th percentile.
Statistical Analyses
We used separate multiple logistic regression models to estimate the children's risk of each cardiometabolic risk factor, defined as $75th percentile, associated with a 1-mmol/L (equivalent to 18 mg/dL) increase in pregnancy glucose, measured 1 hour after a 50-g oral glucose tolerance load. The results were compared with models that used the 50th and 90th percentiles as cut points, as well as linear regression analyses of continuous outcomes. A directed acyclic graph (Figure) 16 guided the selection of adjustment variables. Logistic regression models were adjusted for prepregnancy obesity (body mass index [BMI] $30 kg/m 2 ), soda consumption (times per week) prior to the glucose test (continuous), gestational weight gained prior to the glucose test (continuous), gestational age at the weight measurement (continuous), smoking during pregnancy, poverty, and infant birth weight (continuous). Routine adjustment for gestational age at birth has recently been called into question 17 ; therefore, we present the results of models with and without adjustment for gestational age at birth.
The WC outcome was based on the study cohort's sexspecific WC distributions, as well as sex-specific distributions from a nationally representative sample of 7-year-old Mexican American children 15 ; thus, all models, except for the WC models, included additional adjustment for sex. In the fetal origins of disease literature, the inclusion of an adjustment for current body size in analyses of subsequent hypertension has been debated. 18 Therefore, we conducted the BP analyses with and without additional adjustment for current WC, BMI, and BMI z score 19 (in separate models). Because we hypothesized that current body size was on the causal pathway from in utero glucose exposure to subsequent hypertension, we present the results of models that excluded any adjustment for current body size.
We assessed potential effect modification in the relationship between pregnancy glucose level and each childhood cardiometabolic outcome by maternal prepregnancy obesity, birth weight, and child's sex. Cross products were added, one at a time, to fully adjusted models; no cross products were statistically significant (all P $ .10).
To assess whether loss to follow-up resulted in bias, we compared those included in the study sample to those who were lost to follow-up in regard to the following: maternal educational attainment, marital status, parity, prepregnancy obesity, poverty, and smoking during pregnancy. We also conducted analyses weighted by the inverse probability that a mother-child pair would remain in the cohort and attend the 7-year follow-up visit. SuperLearner, 20 a prediction algorithm, was used to predict whether a pair was assessed at 7 years; prediction was based on the variables just listed, as well as infant birth weight and gestational age at birth.
All analyses were conducted in SAS (version 9.1; SAS Institute, Cary, North Carolina); SuperLearner was run in R (version 2.12.1; The R Foundation for Statistical Computing, Vienna, Austria).
Results
Mother-child pairs who were lost to follow-up (n = 120) did not differ from the study sample (n = 211) in terms of maternal educational attainment, marital status, parity, prepregnancy obesity, and poverty; women who smoked during pregnancy were more likely to be lost to follow-up (P = .01). Characteristics of the 211 mother-child pairs are presented in Table I . More than three-quarters of the women attained less than a high school education. One-half of the women had been in the United States for 5 years or less when they became pregnant and 64% were at or below the poverty line. The mean glucose value at the screening test was 107.1 mg/dL (SD 27.0) (5.9 mmol/L [SD 1.5]), and Figure. Directed acyclic graph. There is no arrow from "poverty" to "birthweight" due to the Latina birth weight paradox. In this Mexican American immigrant population, there is no association between poverty and prepregnancy obesity or between poverty and smoking. mean prepregnancy BMI was 26.9 kg/m 2 (SD 4.9). The average gestational age at the weight measurement prior to the screening test was 22.1 weeks (SD 5.5 weeks) and women gained, on average, 4.9 kg prior to the glucose test (SD 4.2). Thirty-eight percent of the children were obese at age 7 years (BMI z score $95th percentile 19 ). The children's mean total cholesterol was 170.1 mg/dL (SD 29.7; n = 174) and triglycerides was 131.1 mg/dL (SD 82.7; n = 174); boys' WC was 66.2 cm (SD 9.2; n = 98) and girls' WC was 67.3 cm (SD 9.9; n = 112); and DBP was 52.9 mm Hg (SD 5.6; n = 189) and SBP was 96.1 mm Hg (SD 9.0; n = 189).
The 75th percentiles used to define each cardiometabolic risk factor are displayed in Table I . The study cohortspecific 75th percentiles for WC were 71.5 cm and 75.3 cm for boys and girls, respectively, thereby exceeding the nationally representative 75th percentiles for 7-year-old Mexican Americans by 8.1 cm and 12.3 cm, respectively; 51% of the boys and 55% of the girls met or exceeded the nationally representative cut points for Mexican American children.
ORs and 95% CIs for the association between a 1-mmol/L increase in pregnancy glucose level and the presence of each childhood cardiometabolic risk factor are presented in Table II . The ORs for children belonging to the upper quartile of DBP and SBP associated with a 1-mmol/L increase in pregnancy glucose level were 1.39 (95% CI, 1.10-1.75) and 1.38 (95% CI, 1.10-1.73), respectively. Using the nationally representative cut point, the odds of children in the upper quartile of WC were 1.25 (95% CI, 1.02-1.54) times higher for those exposed to a 1-mmol/L increase in maternal glucose level; the estimate for WC defined by the cohort-specific cut point was comparable (1.19 [95% CI, 0.95-1.49]).
Adjustment for child's sex, infant birth weight, and gestational age at birth; maternal prepregnancy obesity, sugarsweetened beverage consumption prior to the glucose test, gestational weight gained prior to the glucose test, gestational age at weight measurement, smoking, and poverty did not appreciably alter the risk estimates (Table II ). In the model for WC defined by the nationally representative cut points, the odds of children belonging to the upper quartile of WC were almost 3 times higher (OR = 2.78 [95% CI, 1.24-6.22]) for the children of obese women compared with the children of nonobese women; the estimate was comparable when WC was defined by the cohort-specific cut point (OR Models that excluded adjustment for infant birth weight and/or gestational age at birth gave comparable estimates ( Table II) . The results of models for BP that included additional adjustment for current body size were comparable with those presented in Table II (data not shown). Models utilizing the 50th and 90th percentiles to define the cardiometabolic risk factors yielded similar results; linear Vol. -, No. -regression analyses also generated similar findings (data not shown). Models adjusted for prepregnancy BMI (continuous) instead of obesity likewise gave comparable estimates (data not shown). Last, estimates obtained from the inverse probability weighted analyses were similar to those presented in Table II (data not shown).
Discussion
Our results are consistent with the findings of previous studies among women with diabetes and GDM. [21] [22] [23] A retrospective cohort study of mother-child pairs belonging to a health maintenance organization in Colorado reported that 82 youth, 6-13 years of age, exposed to maternal GDM in utero had a larger WC than 379 of their unexposed peers. 23 Analyses stratified by Hispanic ethnicity were also presented: Hispanic youth exposed to maternal GDM in utero had a significantly higher WC (7.1 cm) compared with Hispanic youth who were not exposed to GDM, yet the estimate among non-Hispanic white youth (3.4 cm) did not attain statistical significance. A prospective cohort study in China compared 63 youth, 7-10 years of age, who had been exposed to either maternal gestational impaired glucose tolerance (defined as fasting plasma glucose <7.0 mmol/L and 2-hour plasma glucose level $7.8-11.1 mmol/L) or GDM in utero to 101 youth whose mothers had normal glucose tolerance during pregnancy 21 ; youth exposed to maternal GDM or impaired glucose tolerance in utero had higher SBP and DBP. Previous studies have also reported associations between maternal pregnancy hyperglycemia and lower levels of high-density lipoprotein cholesterol in the children but not nonfasting total cholesterol or triglycerides. 21, 22 Given that our results for nonfasting total cholesterol and triglycerides are consistent with these findings, we speculate that the lack of association in the current study was not due to the use of nonfasting blood samples.
Increasing levels of maternal glycemia are associated with increased neonatal adiposity 24 and this disproportionately high fat mass relative to lean body mass is likely to persist, as fetal development is the critical period for muscle growth. 25 The unfavorable body composition that accompanies exposure to increased glucose levels in utero likely leads to the increased cardiometabolic risk observed in this and other studies. [21] [22] [23] The increased growth velocity observed among children exposed to increasing pregnancy glucose levels in utero 26 could also partially explain observations of higher BP in childhood. The US Collaborative Perinatal Project reported that children who had crossed into higher weight percentiles throughout their childhood growth displayed higher BP at 7 years of age. 27 Therefore, developmental programming for increased childhood fat mass and growth velocity could potentially lie on the causal pathway connecting pregnancy glucose levels to increased BP in late childhood.
The prospective design is a clear strength of the current study and essential for examining the effect of any in utero exposure on subsequent childhood obesity. The amount of bias incurred from the use of self-reported prepregnancy weight for a few women also appears to be minimal. Yet, as in any observational study, there are several important limitations to consider. Our estimates likely contain some degree of bias due to residual and unmeasured confounding; shared lifestyle characteristics and/or genetic factors, for example, may have contributed to some or all of the associations described. In addition, the 90th percentile has been used to define children's cardiometabolic outcomes in previous publications but could not be used in this study due to sparse data; specifically, maximum likelihood estimates were not available for the smoking covariate in fully adjusted models for cholesterol, triglycerides, and SBP defined by this cut point.
These findings suggest that lifestyle interventions promoting healthy diet and physical activity to improve pregnancy glucose levels, as well as abdominal obesity and elevated BP in late childhood, should be evaluated as potential strategies to prevent the development of cardiometabolic disease. n ), sugar-sweetened beverage consumption during pregnancy (times per week, continuous), gestational weight gained prior to the glucose test (continuous), gestational age at weight measurement (continuous), smoking (yes/no), and poverty (at/below poverty line vs above). †Model 2 adjusted for Model 1 covariates, plus infant birth weight (continuous). ‡Model 3 adjusted for Model 2 covariates, plus infant's gestational age at birth (continuous). xBased on the study cohort sex-specific distributions; child's sex dropped from the adjusted models. {Based on a nationally representative sample of 7-y-old Mexican American children, sex specific; child's sex dropped from the adjusted models.
